يعرض 1 - 10 نتائج من 10 نتيجة بحث عن '"Rosenblum, Michael"', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Dunstan, Robert W.; Salte, Katherine M.; Todorović, Viktor; Lowe, Margaret; Wetter, Joseph B.; Harms, Paul W.; Burney, Richard E.; Scott, Victoria E.; Smith, Kathleen M.; Rosenblum, Michael D.; Gudjonsson, Johann E.; Honore, Prisca (2021). "Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention." Experimental Dermatology (6): 820-830.; https://hdl.handle.net/2027.42/168326Test; Experimental Dermatology; Melnik BC, Plewig G. Impaired Notch- MKP- 1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology. Exp Dermatol. 2013; 22 ( 3 ): 172 - 177.; Poli F, Wolkenstein P, Revuz J. Back and face involvement in hidradenitis suppurativa. Dermatology. 2010; 221 ( 2 ): 137 - 141.; Frew JW, Hawkes JE, Krueger JG. A systematic review and critical evaluation of immunohistochemical associations in hidradenitis suppurativa. F1000 Res. 2018; 7: 1923.; Plewig G, Kligman AM. The Anatomy of Follicles. Acne and Rosacea. Berlin, Heidelberg (Eds: G Plewig, AM Kligman ): Springer; 2000: 30 - 49.; Panteleyev AA. Functional anatomy of the hair follicle: the secondary hair germ. Exp Dermatol. 2018; 27 ( 7 ): 701 - 720.; Schneider MR, Paus R. Deciphering the functions of the hair follicle infundibulum in skin physiology and disease. Cell Tis Res. 2014; 358 ( 3 ): 697 - 704.; Amoh Y, Kanoh M, Niiyama S, et al. Human and mouse hair follicles contain both multipotent and monopotent stem cells. Cell Cycle. 2009; 8 ( 1 ): 176 - 177.; Yang L, Zhang S, Wang G. Keratin 17 in disease pathogenesis: from cancer to dermatoses. J Pathol. 2019; 247 ( 2 ): 158 - 165.; Commo S, Gaillard O, Bernard BA. The human hair follicle contains two distinct K19 positive compartments in the outer root sheath: a unifying hypothesis for stem cell reservoir? Differentiation. 2000; 66 ( 4- 5 ): 157 - 164.; Kanoh M, Amoh Y, Sato Y, Katsuoka K. Expression of the hair stem cell- specific marker nestin in epidermal and follicular tumors. Eur J Dermatol. 2008; 18 ( 5 ): 518 - 523.; Li L, Mignone J, Yang M, et al. Nestin expression in hair follicle sheath progenitor cells. Proc Natl Acad Sci. 2003; 100 ( 17 ): 9958 - 9961.; Bose A, Teh MT, Mackenzie I, Waseem A. Keratin K15 as a biomarker of epidermal stem cells. Inter J Mol Sci. 2013; 14 ( 10 ): 19385 - 19398.; Welch DR, Hurst DR. Beyond the primary tumor: progression, invasion, and metastasis. In: The Molecular Basis of Human Cancer. New York, NY: Humana Press; 2017: 203 - 216.; Maru GB, Gandhi K, Ramchandani A, Kumar G. The role of inflammation in skin cancer. In: Inflammation and Cancer. Basel, Switzerland: Springer; 2014: 437 - 469.; Selmer J, Skov T, Spelman L, Weedon D. Squamous cell carcinoma and keratoacanthomas are biologically distinct and can be diagnosed by light microscopy: a review. Histopathology. 2016; 69 ( 4 ): 535 - 541.; Ackerman AB. Differentiation of benign from malignant neoplasms by silhouette. Am J Dermatopath. 1989; 11 ( 4 ): 297 - 300.; Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Euro Acad Dermatol Venereol. 2015; 29 ( 4 ): 619 - 644.; Burney RE. 35- year experience with surgical treatment of hidradenitis suppurativa. World J Surg. 2017; 41 ( 11 ): 2723 - 2730.; Kohorst JJ, Baum CL, Otley CC, et al. Surgical management of hidradenitis suppurativa: outcomes of 590 consecutive patients. Dermatol Surg. 2016; 42 ( 9 ): 1030 - 1040.; Lavogiez C, Delaporte E, Darras- Vercambre S, et al. Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa. Dermatology. 2010; 220 ( 2 ): 147 - 153.; Lee CN, Chen W, Hsu CK, Weng TT, Lee JY, Yang CC. Dissecting folliculitis (dissecting cellulitis) of the scalp: a 66- patient case series and proposal of classification. J Dtsch Dermatol Ges. 2018; 16 ( 10 ): 1219 - 1226.; Badaoui A, Reygagne P, Cavelier- Balloy B, et al. Dissecting cellulitis of the scalp: a retrospective study of 51 patients and review of literature. Br J Dermatol. 2016; 174 ( 2 ): 421 - 423.; BrÄ niÅ teanu DE, Molodoi A, Ciobanu D, et al. The importance of histopathologic aspects in the diagnosis of dissecting cellulitis of the scalp. Rom J Morphol Embryol. 2009; 50 ( 4 ): 719 - 724.; Deckers IE, Benhadou F, Koldijk MJ, et al. Inflammatory bowel disease is associated with hidradenitis suppurativa: results from a multicenter cross- sectional study. J Am Acad Dermatol. 2017; 76 ( 1 ): 49 - 53.; Jørgensen AH, Thomsen SF, Karmisholt KE, Ring HC. Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn- s disease. Exp Dermatol. 2020; 29 ( 2 ): 118 - 123.; Tozer PJ, Lung P, Lobo AJ, et al. Pathogenesis of Crohn’s perianal fistula- understanding factors impacting on success and failure of treatment strategies. Aliment Pharm Ther. 2018; 48 ( 3 ): 260 - 269.; Frew JW, Hawkes JE, Krueger JG. A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa. F1000 Res. 2018; 7: 1930.; Schlapbach C, Hänni T, Yawalkar N, Hunger RE. Expression of the IL- 23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2011; 65 ( 4 ): 790 - 798.; Lima AL, Karl I, Giner T, et al. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol. 2016; 174 ( 3 ): 514 - 521.; Burgess DJ. Spatial transcriptomics coming of age. Nat Rev Genet. 2019; 20 ( 6 ): 317.; Saha S, Matthews DA, Bessant C. High throughput discovery of protein variants using proteomics informed by transcriptomics. Nucleic Acids Res. 2018; 46 ( 10 ): 4893 - 4902.; Theut Riis P, Thorlacius LR, Jemec GB. Investigational drugs in clinical trials for hidradenitis suppurativa. Expert Opin Investig Drug. 2018; 27 ( 1 ): 43 - 53.; Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016; 375 ( 5 ): 422 - 434.; Ring HC, Sigsgaard V, Thorsen J, et al. The microbiome of tunnels in hidradenitis suppurativa patients. J Euro Acad Dermatol and Venereol. 2019; 33 ( 9 ): 1775 - 1780.; Chen WT, Chi CC. Association of hidradenitis suppurativa with inflammatory bowel disease: A systematic review and meta- analysis. JAMA Dermatol. 2019; 155 ( 9 ): 1022 - 1027.; Hoffman LK, Ghias MH, Garg A, Hamzavi IH, Alavi A, Lowes MA. Major gaps in understanding and treatment of hidradenitis suppurativa. Semin Cutan Med Surg. 2017; 36 ( 2 ): 86 - 92.; Ralf Paus L, Kurzen H, Kurokawa I, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008; 17 ( 5 ): 455 - 456.; Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009; 60 ( 4 ): 539 - 561.; Yu Ca C- W, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J of Dermatol. 1990; 122 ( 6 ): 763 - 769.; Prens E, Deckers I. Pathophysiology of hidradenitis suppurativa: an update. J Am Acad Dermatol. 2015; 73 ( 5 ): S8 - S11.; Sellheyer K, Krahl D. - Hidradenitis suppurativa- is acne inversa! An appeal to (finally) abandon a misnomer. Int J Dermatol. 2004; 7: 535 - 540.; Laffert MV, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol. 2010; 19 ( 6 ): 533 - 537.; Pink A, Anzengruber F, Navarini AA. Acne and hidradenitis suppurativa. Br J Dermatol. 2018; 178 ( 3 ): 619 - 631.; Chen W, Plewig G. Should hidradenitis suppurativa/acne inversa best be renamed as - dissecting terminal hair folliculitis- ? Exp Dermatol. 2017; 26 ( 6 ): 544 - 547.; Boer J, Weltevreden EF. Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions. Br J Dermatol. 1996; 135 ( 5 ): 721 - 725.; Danby FW, Jemec GB, Marsch WC, Von Laffert M. Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support. Br J Dermatol. 2013; 168 ( 5 ): 1034 - 1039.; Fismen S, Ingvarsson G, Moseng D, et al. A clinical- pathological review of hidradenitis suppurativa: using immunohistochemistry one disease becomes two. Apmis. 2012; 120 ( 6 ): 433 - 440.; Jemec GB, Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol. 1996; 34 ( 6 ): 994 - 999.; Jemec GB, Thomsen BM, Hansen U. The homogeneity of hidradenitis suppurativa lesions: a histological study of intra- individual variation. APMIS. 1997; 105 ( 1- 6 ): 378 - 383.; Kamp S, Fiehn AM, Stenderup K, et al. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol. 2011; 164 ( 5 ): 1017 - 1022.; Kurokawa I, Nishijima S, Kusumoto K, Senzaki H, Shikata N, Tsubura A. Immunohistochemical study of cytokeratins in hidradenitis suppurativa (acne inversa). Int J Med Res. 2002; 30 ( 2 ): 131 - 136.; Kurzen H, Jung EG, Hartschuh W, Moll I, Franke WW, Moll R. Forms of epithelial differentiation of draining sinus in acne inversa (hidradenitis suppurativa). Br J Dermatol. 1999; 141 ( 2 ): 231 - 239.; Lafferty MV, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol. 2010; 19 ( 6 ): 533 - 537.; Saunte DM, Jemec GB. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA. 2017; 318 ( 20 ): 2019 - 2032.; Van der Zee HH, De Ruiter L, Boer J, et al. Alterations in leucocyte subsets and histomorphology in normal- appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. Br J Dermatol. 2012; 166 ( 1 ): 98 - 106.; van der Zee HH, Laman JD, Boer J, Prens EP. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012; 21 ( 10 ): 735 - 739.; von Laffert M, Stadie V, Wohlrab J, Marsch WC. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol. 2011; 164 ( 2 ): 367 - 371.; Vossen AR, van der Zee HH, Prens EP. Hidradenitis Suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model. Front Immunol. 2018; 9: 1 - 12.; Kurokawa I, Jemec GB, et al. What causes hidradenitis suppurativa? Viewpoint 4. Exp Dermatol. 2008; 17 ( 5 ): 462 - 465.; Smith MK, Nicholson CL, Parks- Miller A, Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts. F1000Res. 2017; 6: 1272.; Boer J, Jemec GB. Mechanical stress and the development of pseudo- comedones and tunnels in Hidradenitis suppurativa/Acne inversa. Exp Dermatol. 2016; 25 ( 5 ): 396 - 397.; Gniadecki R, Jemec GB. Lipid raft- enriched stem cell- like keratinocytes in the epidermis, hair follicles and sinus tracts in hidradenitis suppurativa. Exp Dermatol. 2004; 13 ( 6 ): 361 - 363.; Frew JW, Navrazhina K, Marohn M, Lu CP, Krueger JG. Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/Acne Inversa. Exp Dermatol. 2019; 28 ( 8 ): 1 - 6.; Freysz M, Jemec GB, Lipsker D. A systematic review of terms used to describe hidradenitis suppurativa. Br J Dermatol. 2015; 173 ( 5 ): 1298 - 1300.; Otberg N, Richter H, Schaefer H, Blume- Peytavi U, Sterry W, Lademann J. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol. 2004; 122 ( 1 ): 14 - 19.; Vogt A, Hadam S, Heiderhoff M, et al. Morphometry of human terminal and vellus hair follicles. Exp Dermatol. 2007; 16 ( 11 ): 946 - 950.; Lu C, Fuchs E. Sweat gland progenitors in development, homeostasis, and wound repair. Cold Spring Harb. Perspect Med. 2014; 4 ( 2 ): a015222.

  9. 9
  10. 10
    دورية أكاديمية